In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

Research & Insights Whitepapers

Evidence Insight Spotlight: MAKO from Stryker

Is MAKO’s cost justified by the clinical outcomes?

MAKO from Stryker is a robotic orthopedic surgical system used in joint replacement surgeries to achieve highly accurate implant placement. Due to high acquisition and operating costs, health systems must weigh the clinical evidence before adopting this technology.

Download this article to:

  • View MAKO’s operational and clinical outcomes compared to manual surgery across three procedure types
  • Read our evidence-based adoption recommendations for this technology
  • Inform purchasing decisions on a $1M+ outlay